300357 我武生物
按盤價 
29.950 +1.600 (+5.644%)
29.950 +1.600 (+5.644%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 13.824 | 14.005 | 14.896 | 18.773 | 21.178 |
| 總資產報酬率 ROA (%) | 12.312 | 12.059 | 13.033 | 16.890 | 19.113 |
| 投入資產回報率 ROIC (%) | 13.626 | 13.573 | 14.421 | 18.506 | 21.113 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.374 | 95.158 | 95.262 | 95.393 | 95.736 |
| 營業利潤率 (%) | 46.604 | 39.887 | 40.672 | 44.219 | 48.645 |
| 息稅前利潤/營業總收入 (%) | 43.755 | 36.157 | 37.312 | 41.799 | 45.914 |
| 淨利潤/營業總收入 (%) | 39.284 | 32.887 | 34.841 | 37.469 | 40.398 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.845 | 94.994 | 96.618 | 102.515 | 94.079 |
| 價值變動淨收益/利潤總額(%) | 0.467 | 1.772 | 0.360 | 0.676 | 1.600 |
| 營業外收支淨額/利潤總額(%) | -0.867 | -1.109 | 0.284 | 0.637 | 0.023 | 償債能力分析 |
| 流動比率 (X) | 14.775 | 9.045 | 8.867 | 14.376 | 12.422 |
| 速動比率 (X) | 14.327 | 8.729 | 8.534 | 13.905 | 11.924 |
| 資產負債率 (%) | 5.599 | 9.239 | 10.088 | 7.769 | 7.006 |
| 帶息債務/全部投入資本 (%) | -0.825 | -0.639 | 0.467 | -1.137 | -1.068 |
| 股東權益/帶息債務 (%) | -12,030.274 | -15,316.149 | 20,537.318 | -8,595.943 | -9,315.131 |
| 股東權益/負債合計 (%) | 1,627.187 | 940.372 | 845.429 | 1,159.304 | 1,282.590 |
| 利息保障倍數 (X) | -17.871 | -10.984 | -10.734 | -15.460 | -16.742 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 65.874 | 57.571 | 66.650 | 65.734 | 64.711 |
| 存貨周轉天數 (天) | 381.102 | 469.069 | 481.237 | 445.498 | 533.562 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/01/2026 10:15 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
